Dr. Lauren L. Woolbert, MD
Family Medicine (Family Medicine Physician)
- Medicare participating
At a glance
- Medical school
- University of Texas Medical Branch at Galveston (2014)
- Years since graduation
- 12
- In the NPI registry since
- 2014
- Medicare patients seen, 2024
- 193
Licensed in Texas since 2017, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2014Medical school: University of Texas Medical Branch at Galveston
- 2014Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Medicine Physician primary
TX license R3010 (first issued 2017; active) -
Student in an Organized Health Care Education/Training Program
TX license BP10051254
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Medical City Plano Plano, TX
- Baylor Scott & White Medical Center Plano Plano, TX
- Medical Center of Mckinney Mckinney, TX
- Texas Health Presbyterian Hospital Allen Allen, TX
Medical groups
- Catalyst Physician Group - Ntx, PLLC (86 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 193
- Services billed
- 842
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 138 | 73 |
| Established patient office or other outpatient visit, 20-29 minutes | 56 | 37 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 40 | 40 |
| Administration of influenza virus vaccine | 16 | 16 |
| Influenza vaccine split virus, preservative free | 14 | 14 |
| Annual depression screening, 5 to 15 minutes | 13 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Plano, TX | 223 |
| Atorvastatin Calcium Other prescribers in Plano, TX | 198 |
| Rosuvastatin Calcium Other prescribers in Plano, TX | 196 |
| Losartan Potassium Other prescribers in Plano, TX | 124 |
| Amlodipine Besylate Other prescribers in Plano, TX | 104 |
| Metformin Hcl Er (metformin hcl) Other prescribers in Plano, TX | 96 |
| Gabapentin Other prescribers in Plano, TX | 92 |
| Ozempic (semaglutide) Other prescribers in Plano, TX | 87 |
| Hydrochlorothiazide Other prescribers in Plano, TX | 78 |
| Pantoprazole Sodium Other prescribers in Plano, TX | 73 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 45 payments worth $879 in total to this clinician.
| AbbVie Inc. | $178 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $171 |
| Novo Nordisk Inc | $139 |
| Astellas Pharma US Inc | $104 |
| Pfizer Inc. | $45.83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $44.03 |
| Dexcom, Inc. | $40.49 |
| Abbott Laboratories | $36.26 |
| Food and Beverage | $879 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $43,680 in research payments for these studies, mostly to the institutions running them.
- A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age
ModernaTX, Inc. · Terminated · NCT05085366
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.